key takeaway 4: right-sided tumors: anti-angiogenic treatment
Published 4 years ago • 93 plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
6:32
antiangiogenic therapy for metastatic colorectal cancer
-
4:41
key takeaway 3: determining tumor mutational status
-
4:19
antiangiogenic treatments for metastatic colorectal cancer
-
4:24
anti-angiogenesis: cutting off tumor supply lines
-
4:34
key takeaways from esmo: colorectal cancer
-
7:36
angiogenesis in tumor growth and metastasis
-
22:35
expert perspectives: anti-angiogenesis and immune therapy for cancer
-
0:50
dr. chung: should anti-angiogenesis therapy be continued in this patient?
-
8:46
antibody selection and right- versus left-sided colorectal cancer
-
0:32
dr. eng: continuation of anti-angiogenesis therapy
-
4:11
crossroads: terrible topology -- extrachromosomal circular dna in cancer
-
15:35
healthier lives 2016 kōrero tahi – tumour dna biomarkers for cancer detection (parry guilford)
-
29:57
icaho 2017 - dr. r. govindan
-
3:07
targeting angiogenesis in non–small cell lung cancer
-
2:04
screenings are key for cancer prevention and treatment
-
9:48
interplay between angiogenesis and immunity
-
15:55
enhancing outcomes in metastatic colorectal cancer with angiogenesis inhibitors
-
4:24
case 4: multiple lines of therapy in recurrent bladder cancer
-
1:51
the inadequacy of the current standard of care for glioblastoma